MedPath

KurCoSmart Effects on People With Type 2 DM

Phase 1
Conditions
Inflammation
Diabetes Mellitus, Type 2
Insulin Resistance
Body Weight
Registration Number
NCT05407467
Lead Sponsor
Universitas Sebelas Maret
Brief Summary

The investigators aim to evaluate the effect of curcumin and virgin coconut oil extract supplementation on people with type 2 DM, including blood glucose, HbA1c levels, inflammation, body weight and insulin resistance evaluation

Detailed Description

The investigators give Kurcosmart supplementation aside from diabetes standard treatment to evaluate its benefits on people with type 2 DM, considering its effect on controlling fasting and prandial blood glucose, reducing HbA1c level, controlling inflammation degree; and repairing insulin resistance

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Confirmed Type 2 DM
  • Signing consent form
Exclusion Criteria
  • Pregnant or breastfeeding
  • Multiple organ failure
  • History of hypersensitivity reaction to curcumin and virgin coconut oil
  • Cancer, renal insufficiency, hematological disease, acute heart failure, chronic liver disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Blood glucoseChange of Blood glucose at 1 months

Subject's fasting and prandial blood glucose

insulin resistanceChange of HOMA IR at 1 Months

Subject's HOMA IR

HbA1cChange of HbA1C at 1 Months

Subject's glycated haemoglobin level

Inflammation degreeChange of hs-CRP at 1 Months

Subject's high sensitivity C-reactive protein level

Secondary Outcome Measures
NameTimeMethod
Body Mass IndexChange of BMI at 1 Months

Subject's height and body weight

Blood PressureChange fof blood prssure at 1 Months

Subject's blood pressure

Trial Locations

Locations (1)

UNS Hospital

🇮🇩

Sukoharjo, Central Java, Indonesia

UNS Hospital
🇮🇩Sukoharjo, Central Java, Indonesia
Desy Puspa Putri, Master
Sub Investigator
Nurhasan Agung Prabowo, Master
Principal Investigator
Yulia Sari, Doctor
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.